Bard Associates Inc Isoray, Inc. Transaction History

Bard Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$0.22 - $0.43 $330 - $645	-1,500 Reduced 0.22%	667,700 $154,000
Q1 2022 May 11, 2022	BUY	$0.31 - $0.41 $15,500 - $20,500	50,000 Added 8.07%	669,200 $243,000
Q4 2021 Feb 14, 2022	BUY	$0.38 - $0.68 $26,980 - $48,280	71,000 Added 12.95%	619,200 $240,000
Q3 2021 Nov 12, 2021	BUY	$0.58 - $0.79 $6,264 - $8,532	10,800 Added 2.01%	548,200 $346,000
Q2 2021 Aug 12, 2021	BUY	$0.75 - $1.15 $115,800 - $177,560	154,400 Added 40.31%	537,400 $429,000
Q1 2021 May 13, 2021	BUY	$0.53 - $2.47 $202,990 - $946,010	383,000 New	383,000 $417,000

145K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Bard Associates Inc with notifications on news.